Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Weighted Average Inputs and Assumptions

	September 30,			September 30,
	2023			2022
Grant date stock price and exercise price	$	12.03		$	15.80
Dividend yield		2.89	%		2.48	%
Expected stock price volatility		23.37	%		23.59	%
Risk-free interest rate		3.50	%		2.17	%
Expected option life in years		6			6
Total weighted-average fair value of options granted	$	2.42		$	3.00

A summary of stock option activity in 2023 is presented below (Intrinsic Value in 000s):

A summary of stock option activity in 2023 is presented below (Intrinsic Value in 000s):

						Weighted-
				Weighted-		Average
	Shares			Average		Remaining		Aggregate
	Subject to			Exercise		Contractual		Intrinsic
	Options			Price		Term		Value
Outstanding at June 30, 2023		145,750		$	14.08		2.5 Years	$	29
Granted		—			—		—		—
Exercised		—			—		—		—
Forfeited or expired		(1,250	)	$	12.03		4.5 Years		—
Outstanding at September 30, 2023		144,500		$	13.91		2.4 Years	$	—
Exerciseable at September 30, 2023		111,700		$	14.46		1.5 Years	$	—

						Weighted-
				Weighted-		Average
	Shares			Average		Remaining		Aggregate
	Subject to			Exercise		Contractual		Intrinsic
	Options			Price		Term		Value
Outstanding at December 31, 2022		144,020		$	14.07		2.8 Years	$	95
Granted		10,250			12.03		6.8 years		—
Exercised		—			—		—		—
Forfeited or expired		(9,770	)	$	14.26		2.5 Years		—
Outstanding at September 30, 2023		144,500		$	13.91		2.4 Years	$	—
Exerciseable at September 30, 2023		111,700		$	14.46		1.5 Years	$	—

A summary of stock option activity in 2022 is presented below (Intrinsic Value in 000s):

						Weighted-
				Weighted-		Average
	Shares			Average		Remaining		Aggregate
	Subject to			Exercise		Contractual		Intrinsic
	Options			Price		Term		Value
Outstanding at June 30, 2022		156,820		$	13.94		3.1 Years	$	123
Granted		—			—		—		—
Exercised		—			—		—		—
Forfeited or expired		(4,200	)		14.63		3.6 Years		—
Outstanding at September 30, 2022		152,620		$	14.07		2.9 Years	$	125
Exerciseable at September 30, 2022		118,020		$	14.45		2.2 Years	$	56
						Weighted-
				Weighted-		Average
	Shares			Average		Remaining		Aggregate
	Subject to			Exercise		Contractual		Intrinsic
	Options			Price		Term		Value
Outstanding at December 31, 2021		163,600		$	13.94		3.6 Years	$	118
Granted		15,000			15.80		6.5 Years		—
Exercised		(13,200	)		14.90		—		17
Forfeited or expired		(12,780	)		13.57		4.3 Years		—
Outstanding at September 30, 2022		152,620		$	14.07		2.9 Years	$	125
Exerciseable at September 30, 2022		118,020		$	14.45		2.2 Years	$	56

Schedule of Non-Vested Restricted Stock Activity

A summary of restricted stock activity for the three and nine months ended September 30, 2023, is presented below:

				Weighted-		Average
				Average		Remaining
				Grant Date		Contractual
	Shares			Fair Value		Term
Non-vested on June 30, 2023		15,450		$	12.99	4.4 Years
Granted		—			—
Vested		—			—
Forfeited		(1,250	)		12.03	4.5 years
Non-vested on September 30, 2023		14,200		$	13.08	4.1 years
				Weighted-		Average
				Average		Remaining
				Grant Date		Contractual
	Shares			Fair Value		Term
Non-vested on December 31, 2022		6,500		$	14.89	4.1 years
Granted		10,250			12.03	4.5 years
Vested		(1,300	)		14.89	3.6 years
Forfeited		(1,250	)		12.03	4.5 years
Non-vested on September 30, 2023		14,200		$	13.08	4.1 years

A summary of restricted stock activity for the three and nine months ended September 30, 2022, is presented below:

				Weighted-		Average
				Average		Remaining
				Grant Date		Contractual
	Shares			Fair Value		Term
Non-vested on June 30, 2022		18,750		$	14.02	2.9 years
Granted		—			—
Vested		(500	)		12.24	3.8 years
Forfeited		—			—
Non-vested on September 30, 2022		18,250		$	14.61	2.6 Years
				Weighted-		Average
				Average		Remaining
				Grant Date		Contractual
	Shares			Fair Value		Term
Non-vested on December 31, 2021		12,774		$	14.02	2.0 years
Granted		9,500			14.92	4.6 years
Vested		(585	)		14.75	3.3 years
Forfeited		(3,439	)		12.59	2.9 years
Non-vested on September 30, 2022		18,250		$	14.61	2.6 Years

Schedule of Unrecognized Equity-Based Expense under 2017 Equity Incentive Plan

Year
2023	$	17
2024		67
2025		64
2026		52
2027		30
2028		6
Totals	$	236